Skip to main content

Drug companies try to catch the rising wave of RNAi medicines

By 07.11.2018September 17th, 2020Features

You May Also Like

AllFeatures BaseLaunch Summer Get-Together 2025

BaseLaunch Summer Get-Together 2025

oliver.stula@baselarea.swiss
oliver.stula@baselarea.swiss02.07.2025
AllFeatures FimmCyte obtains CHF 1 million from the UZH Life Sciences Fund

FimmCyte obtains CHF 1 million from the UZH Life Sciences Fund

andy
andy29.02.2024
AllFeatures Synendos Therapeutics granted EMA clinical trial authorisation

Synendos Therapeutics granted EMA clinical trial authorisation

andy
andy18.01.2024
Share